In this issue:
EPS in black Africans with first-episode schizophrenia and first exposure to antipsychotics
Anticholinergic medication burden-associated cognitive impairment in schizophrenia
Efficacy and heterogeneity of antipsychotic response in schizophrenia
Genetic risk and association of childhood abuse with mental illness
Feasibility of remotely accessed cognitive remediation for schizophrenia
Age-specific prevalence of dementia diagnosis among older US adults with schizophrenia
Comparing LAI discontinuation rates in a real-world setting
Clinical and economic impact of LAI vs oral antipsychotics among patients with schizophrenia in the US
Gender disparities in clozapine prescription in a cohort of treatment-resistant schizophrenia
Impact of paliperidone palmitate 3-monlthy for schizophrenia
Please login below to download this issue (PDF)